Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase III (Pol III) is a multi-subunit enzyme responsible for transcribing DNA into various small, non-coding RNAs, including tRNAs, 5S rRNA, and U6 snRNA. It plays essential roles in cellular function, innate immunity, and DNA repair. Pol III is a therapeutic target for diseases involving dysregulated transcription and viral infections.
Inhibition of RNA Polymerase III activity
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA Polymerase III (Pol III).